MCM
RGN

MAI Capital Management’s REGENERX BIOPHARMACEUTICALS RGN Stock Holding History

MAI Capital Management’s Portfolio RGN Stock Details RGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-20,000
Closed -$3K – 1056
2022
Q2 		$3K Buy
+20,000
New +$3K ﹤0.01% 885

Other funds holding RGN

WJWM
Williams Jones Wealth Management New York $8.14B AUM 19.32% 1-Year Est. Return

MAI Capital Management's RGN Position: Q3 2022 in Review

MAI Capital Management sold out of REGENERX BIOPHARMACEUTICALS (RGN) in Q3 2022, closing a stake of 20,000 shares — an estimated $3K sold.

MAI Capital Management first reported a position in RGN in Q2 2022 and held it in 1 quarter. The position peaked at $3K in Q2 2022. 1 fund tracked by Wall St. Rank holds RGN as of Q3 2022.

  • MAI Capital Management reported no remaining REGENERX BIOPHARMACEUTICALS position as of Q3 2022 after selling out during the quarter.
  • MAI Capital Management sold 20,000 REGENERX BIOPHARMACEUTICALS shares in Q3 2022, an estimated $3K.
  • MAI Capital Management first reported a position in REGENERX BIOPHARMACEUTICALS in Q2 2022 and held it in 1 quarter.
  • MAI Capital Management's REGENERX BIOPHARMACEUTICALS position peaked at $3K in Q2 2022.
  • 1 fund tracked by Wall St. Rank held REGENERX BIOPHARMACEUTICALS as of Q3 2022.

Based on MAI Capital Management's 13F filing for Q3 2022, filed 15 Nov 2022.